Acorah Software Products - Accounts Production 14.5.501 false true false true No description of principal activity 26 September 2022 30 September 2023 30 September 2023 14376760 Dr Amy Shields iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14376760 2022-09-25 14376760 2023-09-30 14376760 2022-09-26 2023-09-30 14376760 frs-core:CurrentFinancialInstruments 2023-09-30 14376760 frs-bus:PrivateLimitedCompanyLtd 2022-09-26 2023-09-30 14376760 frs-bus:FilletedAccounts 2022-09-26 2023-09-30 14376760 frs-bus:Micro-entities 2022-09-26 2023-09-30 14376760 frs-bus:AuditExempt-NoAccountantsReport 2022-09-26 2023-09-30 14376760 frs-bus:Director1 2022-09-26 2023-09-30
Registered number: 14376760
Amy Shields Limited
Unaudited Financial Statements
For The Year Ended 30 September 2023
The Arkk Alliance Ltd
Balance Sheet
Registered number: 14376760
2023
£
Fixed assets 7,336
Current assets 14,226
Creditors: Amounts Falling Due Within One Year (6,921 )
NET CURRENT ASSETS 7,305
TOTAL ASSETS LESS CURRENT LIABILITIES 14,641
NET ASSETS 14,641
CAPITAL AND RESERVES 14,641

Notes

1. General Information
Amy Shields Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14376760 . The registered office is 20-22 First Floor Station Road, Solihull, Knowle, B93 0HT.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Amy Shields
Director
27th November 2023